Summary
The report highlights the importance of addressing racial disparities in prostate cancer outcomes. **Native American men** have 12% higher mortality rates than **White men**, despite lower incidence rates. The **American Cancer Society Cancer Action Network** supports legislation to waive cost-sharing requirements for prostate cancer screening tests for high-risk men. To learn more about the **Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act**, visit [[psa-screening-for-him-act|PSA Screening for HIM Act]]. For information on **cancer advocacy**, see [[cancer-advocacy|Cancer Advocacy]].
Key Takeaways
- Prostate cancer incidence rates have increased by 3.0% annually from 2014 to 2021
- Mortality rates for prostate cancer have declined slowly, with a 0.6% annual decline over the past decade
- Black men experience mortality rates twice as high as White men for prostate cancer
- The American Cancer Society recommends that men discuss screening with their healthcare provider at age 50, or 45 for those with a family history of prostate cancer
- The PSA Screening for HIM Act aims to increase access to screening tests for high-risk men
Balanced Perspective
The report highlights the complex issue of prostate cancer incidence and mortality rates. While the increase in advanced-stage diagnoses is concerning, the slow decline in mortality rates suggests that treatment and screening efforts are having some impact. The racial disparities in prostate cancer outcomes are a significant concern, and addressing these disparities will require a multifaceted approach. To learn more about **health disparities**, visit [[health-disparities|Health Disparities]].
Optimistic View
The slow decline in mortality rates is a positive trend, and the increased awareness of prostate cancer may lead to more men seeking screening and treatment. The **American Cancer Society**'s efforts to promote early detection and screening may help reduce racial disparities in prostate cancer outcomes. With the support of legislation like the **PSA Screening for HIM Act**, more men may have access to life-saving screening tests. For more on **healthcare policy**, see [[healthcare-policy|Healthcare Policy]].
Critical View
The increase in prostate cancer incidence rates and the slow decline in mortality rates are alarming trends. The racial disparities in prostate cancer outcomes are unacceptable, and the lack of progress in addressing these disparities is concerning. The **American Cancer Society**'s efforts to promote early detection and screening may not be enough to address the complex issues surrounding prostate cancer. For more information on **cancer research**, see [[cancer-research|Cancer Research]].
Source
Originally reported by pressroom.cancer.org